We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a sequential parallel comparison design to evaluate the efficacy and safety of extended-release ...
—TRIADE Designed to Address Excessive Placebo Response, a Prime Cause of Depression Trial Failure— —Trial Further Evaluates Amitifadine, Euthymics’ Proprietary Serotonin-Preferring Triple— CAMBRIDGE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results